Revenue from GSK's vaccines came up short Wednesday, including the drugmaker's household name shot, Shingrix.
We are experiencing some temporary issues. The market data on this page is currently delayed.
Yahoo
Skip to navigation
Skip to main content
Skip to right column
GSK Fumbles On Vaccines, HIV — Reversing An 11% Pre-Earnings Run ·
Investor's Business Daily
